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Abstract: Staphylococcus aureus is a serious human pathogen that employs a number of 
virulence factors as part of its pathogenesis. The purpose of the present study was to 
explore marine bacteria as a source of compounds that modulate virulence gene expression 
in S. aureus. During the global marine Galathea 3 expedition, a strain collection was 
established comprising bacteria that express antimicrobial activity against Vibrio anguillarum 
and/or Staphylococcus aureus. Within this collection we searched colony material, culture 
supernatants, and cell extracts for virulence modulating activity showing that 68 out of  
83 marine bacteria (affiliated with the Vibrionaceae and Pseudoalteromonas sp.) influenced 
expression of S. aureus hla encoding α-hemolysin toxin and/or spa encoding Protein A. 
The isolate that upon initial screening showed the highest degree of interference (crude 
ethyl acetate extract) was a Vibrio nigripulchritudo. Extraction, purification and structural 
elucidation revealed a novel siderophore, designated nigribactin, which induces spa 
transcription. The effect of nigribactin on spa expression is likely to be independent from 
its siderophore activity, as another potent siderophore, enterobactin, failed to influence  
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S. aureus virulence gene expression. This study shows that marine microorganisms 
produce compounds with potential use in therapeutic strategies targeting virulence rather 
than viability of human pathogens. 
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1. Introduction 
The marine environment has proven to be a reservoir of microorganisms producing compounds 
with interesting biomedical properties [1]. Examples of such compounds include thiopeptides from a 
sponge-associated Bacillus cereus strain with antibacterial activity against multiple drug resistant 
strains of staphylococci and enterococci [2]; andrimid, a broad spectrum antibiotic produced by  
Vibrio coralliilyticus [3], and the antibiotic holomycin that interferes with RNA synthesis purified 
from Photobacterium halotolerans [3]. While new antibacterial compounds may prove efficient in 
treating infectious diseases, human pathogens have a profound ability to acquire resistance resulting in 
serious health care problems. These include methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant Enterococcus as well as extended-spectrum cephalosporin-resistant Escherichia 
coli and Klebsiella pneumoniae [4,5]. To address the therapeutic failures associated with antibiotic 
resistance, other strategies, including anti-virulence therapies, are being considered. Antivirulence 
agents inhibit the production or activity of disease-causing factors of the infecting organism, and 
thereby disarm the pathogen of its virulence traits [6]. As quorum-sensing (QS) signalling systems are 
central regulators of virulence gene expression in many pathogens while being absent in humans, they 
represent highly promising targets for the development of anti-virulence therapeutics, possibly in 
combination with traditional antibiotics [7–9]. Several quorum sensing inhibitors (QSIs) targeting QS 
systems in Gram-negative pathogens have been identified, including ajoene from garlic that reduces 
the infective ability of Pseudomonas aeruginosa in a pulmonary infectious mouse model [10].  
In Gram-positive bacteria, QS is commonly mediated by auto-inducing cyclic peptides. One 
example is the agr quorum sensing system in Staphylococcus aureus [11]. S. aureus causes a variety of 
infections ranging from mild skin infections to life-threatening bacteremia and endocarditis, with many 
strains being resistant to a number of antibiotics [12]. Pathogenesis of S. aureus is attributed to a 
multitude of virulence factors, of which a major part is controlled by agr [11]. The agr QS system is 
composed by an external signal, an autoinducing cyclic peptide that upon binding to the  
membrane-bound sensor histidine kinase (AgrC) activates the response regulator AgrA and induces 
virulence gene expression via a regulatory RNA, RNAIII [13,14]. Activation of agr results in 
expression of extracellular virulence factors including the key toxin, α-hemolysin, while cell  
surface-associated virulence factors, such as Protein A, are repressed [14]. Previously, we identified a 
putative QSI compound produced by the marine bacterium Photobacterium halotolerans that 
dramatically reduces hla and RNAIII expression while increasing spa production [15]. To address how 
abundant such compounds are in the marine environment we have screened a collection of marine 
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3. Experimental Section 
3.1. Bacterial Strains 
Of 512 marine bacterial strains isolated during the global Galathea 3 expedition [16], 83 strains 
were selected for the present study. The screening assay applied in this study is described by [17] using 
S. aureus strains carrying different gene reporter fusions, including S. aureus 8325-4 hla::lacZ [26],  
S. aureus 8325-4 spa::lacZ [26] and S. aureus 8325-4 rnaIII::lacZ [27,28]. S. aureus strain 8325-4 [29] 
was used for Northern blot analyses. 
3.2. Bacterial Growth Conditions, Culture Extraction and Virulence Gene Expression Assay 
Marine bacteria were grown in 30 mL sea salt solution (SSS; Sigma S9883; 40 g·L−1) with 0.4% 
glucose and 0.3% casamino acids for three days at 25 °C with (200 rpm) and without (0 rpm) aeration. 
Culture supernatants were prepared by sterile filtration. Cultures were extracted with an equal volume 
of EtOAc, transferring the organic phase to a new vial, and evaporating under nitrogen gas until 
dryness. Fractionation by explorative solid-phase extraction (E-SPE) was performed according to [20]. 
Dry extracts and fractions were redissolved in 300 µL 80% EtOH for biological testing as described  
in [17]. For screening of colony material, marine bacteria were grown on Marine Agar 2216  
(Difco 212185) for 24 h at 25 °C, and a lump of colony material was placed on top of agar plates 
containing S. aureus [17] but without wells in the plates, and incubated for 48 h at 30 °C. By using a 
combination of reporter strains looking for both up- and -down regulation, we were able to detect and 
exclude strains being natural producers of β-galactosidase. 
3.3. Northern Blot Analysis 
S. aureus 8325-4 was grown in TSB at 37 °C at 200 rpm. Nigribactin was added at OD600 = 0.4 and 
samples for RNA extraction were taken after 30 and 90 min. Northern blot analysis using a probe  
targeting spa was performed as described previously [30]. Probes were made using the primers spa 
forward (5′-GGG GGT GTA GGT ATT GCA TCT G-3′) and spa reverse (5′-GGG GCT CCT GAA 
GGA TCG TC-3′). 
3.4. Purification and Structural Elucidation of Nigribactin 
Strain S2604 was grown in 2 L sea salt solution (Sigma S9883; 40 g·L−1) with 0.4% melibiose and 
0.3% casamino acids for three days (0 rpm) at 25 °C. On day 3, the culture was extracted with 750 mL 
EtOAc for 24 h. The organic extract was dry loaded onto 10 g Sepra ZT C18 (Phenomenex, Torrance, CA) 
and dried before packing into a 60 g SNAP column (Biotage, Uppsala, Sweden) with 50 g pure resin in 
the base. Using an Isolera flash purification system (Biotage) the extract was subjected to a crude 
fractionation using an acetonitrile (MeCN)/H2O gradient (flow rate 40 mL·min−1) starting with 10% 
MeCN (2 column volumes (CV), isocratic), increasing to 100% MeCN (10 CV) before washing with 
100% MeCN (2 CV). Fractions were automatically collected using UV detection (210 and 320 nm). 
The fractions inducing spa activity (120 mg) were pooled, evaporated, and redissolved in 1.2 mL 
EtOAc/methanol (MeOH; 1:3 v/v) for diol separation (Isolute diol, Biotage) on the Isolera system.  
Mar. Drugs 2012, 10 2591 
 
 
A total of nine fractions (fraction size 12 mL) were collected from the diol column (10 g SNAP column) 
ranging from heptane, dichloromethane (DCM), EtOAc to pure MeOH, running under gravity. The 
fractions (28 mg total) with spa activity (25% DCM in heptane to 100% MeOH) were pooled and 
purified on a Luna II C18 column (250 × 10 mm, 5 μm) (Phenomenex) using a 45%–70% MeCN/H2O 
gradient (buffered with 20 mM formic acid, flow rate 4 mL·min−1) over 20 min on a Gilson 322 liquid 
chromatograph with a 215 liquid handler/injector (BioLab, Risskov, Denmark). All fractions were 
analysed by LC-UV-MS according to standard procedures [20] before pooling. This yielded 1.6 mg  
of nigribactin.  
NMR spectra were recorded on a Varian Unity Inova 500 MHz spectrometer equipped with a 5 mm 
probe using standard pulse sequences. 13C data was confirmed on a Bruker Avance 800 MHz 
spectrometer at the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules. 
The NMR data used for the structural assignment of nigribactin (Figure 7) were acquired in DMSO-d6 
(Table 2). 
Figure 7. Structure of nigribactin with numbered atoms as assigned in Table 2. 
 
Table 2. NMR spectroscopic data (DMSO-d6) of nigribactin. 
Atom δC (ppm) δH (ppm) (multiplicity, J (Hz)) HMBC 
1a 43.2 3.38 (1H, m) 1′, 2, 3, 12 
1b 43.2 3.36 (1H, m) 1′, 2, 3, 12 
2 26.8 1.77 (2H, m) - 
3 36.3 3.26 (2H, m) 1, 2, 5 
4 - 8.74 5 
5 169.4 - - 
6 114.8 - - 
7 149.4 - - 
8 145.9 - - 
9 118.6 6.88 (1H, d, 7.6) 7, 8, 11 
10 117.7 6.65 (1H, t, 7.6) 6, 8 
11 116.9 7.22 (1H, d, 8.0) 5, 7, 9 
1′a 44.6 3.68 (1H, m) 2′, 12 
1′b 44.6 3.56 (1H, m) 2′, 12 
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Table 2. Cont.  
2′ 28.2 1.95 (2H, p, 7.2) 1′, 3′ 
3′ 36.3 3.38 (2H, m) 1′, 2′, 5′ 
4′ - 8.83 5′ 
5′ 169.6 - - 
6′ 114.8 - - 
7′ 149.4 - - 
8′ 145.9 - - 
9′ 118.6 6.88 (1H, d, 7.6) 7′, 8′, 11′ 
10′ 117.7 6.65 (1H, t, 7.6) 6′, 8′ 
11′ 116.9 7.26 (1H, d, 8.0) 5′, 7′, 9′ 
12 168.3 - - 
13 64.2 5.36 (dd, 9.5, 6.7) 12, 15 
14a 69.2 4.77 (1H, t, 7.5) 12, 13, 15 
14b 69.2 4.54 (1H, t, 8.9) 12, 15 
15 165.3 - - 
16 109.6 - - 
17 158.6 - - 
18 116.4 6.97 (1H, d, 8.3) 16, 17, 20 
19 133.9 7.44 (1H, t, 7.9) 17, 21 
20 118.9 6.93 (1H, t, 7.6) 16, 18 
21 127.9 7.62 (1H, dd, 7.8, 1.1) 17, 19 
22 (–OH) - 11.7 16, 17, 18 
–OH - 12.7 - 
–OH - 12.6 - 
–OH - 9.12 - 
–OH - 9.09 - 
4. Conclusions 
This study shows that a substantial number of marine bacteria (80%), collected from various  
marine habitats worldwide, are able to influence S. aureus virulence gene expression. From Vibrio 
nigripulchritudo we isolated a new siderophore, nigribactin, which enhances the expression of spa 
encoding Protein A. While the crude extract of this bacterium also showed hla-repressing activity, we 
failed to isolate a single compound both repressing hla and inducing spa expression. However, since a 
large number of strains displayed this combination of activities such compounds are likely to be 
abundant. From a biological perspective, it is intriguing that bacteria from marine habitats produce 
compounds that influence virulence gene expression of a pathogen normally associated with  
warm-blooded animals. Thus, our study shows that marine bacteria are a source of compounds that 
affect virulence gene expression in S. aureus and ultimately, such compounds may aid in the treatment 
of infectious diseases. 
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